Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis

Arroliga, A., Balk, R., Cannon, C., Dean, N., Dellinger, P., Dennen, P., … Taylor, R. (2014). Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Critical Care Medicine. Lippincott Williams and Wilkins. https://doi.org/10.1097/CCM.0000000000000348